THE RISK FACTORS OF BLOOD-BRAIN BARRIER DISRUPTION AFTER ENDOVASCULAR TREATMENT IN PATIENTS WITH CEREBRAL INFARCTION AND ITS RELATIONSHIP WITH EARLY PROGNOSIS

被引:0
作者
Wang, Yan [1 ]
Cai, Chunqian [2 ]
Hu, Jinquan [3 ,4 ]
机构
[1] Characterist Med Ctr Chinese Peoples Armed Police, Neurotrauma Rehabil, Tianjin 300162, Peoples R China
[2] Tianjin Univ Tradit Chinese Med, Teaching Hosp 1, Natl Clin Res Ctr Chinese Med Acupuncture & Moxibu, Acupuncture & Moxibust Dept, Tianjin 300381, Peoples R China
[3] Hubei Univ Med, Taihe Hosp, Dept Neurol, Shiyan 442000, Peoples R China
[4] Hubei Univ Med, The Hosp, 32 Renmin Rd, Shiyan City, Hubei, Peoples R China
来源
ACTA MEDICA MEDITERRANEA | 2023年 / 39卷 / 01期
关键词
Cerebral infarction; endovascular treatment; blood-brain barrier disruption; prognosis; PERIVASCULAR SPACES;
D O I
10.19193/0393-6384_2023_1_43
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: To explore the risk factors of blood-brain barrier disruption after endovascular treatment in patients with cerebral infarction and its relationship with early prognosis, so as to provide more reference for subsequent prognosis evaluation and the development of more targeted therapeutic schedule.Materials and methods: 334 patients with cerebral infarction undergoing endovascular treatment in our hospital from January 2018 to June 2022 were included in this study. They were divided into destruction group (202 cases) and intact group (132 cases) according to the presence or absence of blood-brain barrier disruption. Univariate and multivariate analyses were employed to evaluate the risk factors of blood-brain barrier disruption after endovascular treatment, and analyze the correlation between blood -brain barrier disruption and poor early prognosis.Results: There were statistically significant differences between two groups in concurrent diabetes, randomized blood glucose level, baseline NIHSS score, concurrent cardiogenic embolism, concurrent internal carotid/middle cerebral artery occlusion, poor rate of early prognosis and 90-day follow-up mortality (P<0.05). The results of univariate and multivariate analyses of logistic regression model indicated that baseline NIHSS score, concurrent cardiogenic embolism and middle cerebral artery occlusion were independent influence factors of blood-brain barrier disruption after endovascular treatment (P<0.05). The incidence of blood-brain barrier disruption in poor prognosis subgroup was significantly higher than that in good prognosis subgroup (P<0.05). Multivariate analysis of logistic regression model showed that the occurrence of blood-brain barrier disruption was independently related to poor early prognosis after endovascular treatment (P<0.05).Conclusion: The occurrence of blood-brain barrier disruption after endovascular treatment in patients with cerebral infarction is independently related to baseline NIHSS score, concurrent cardiogenic embolism and middle cerebral artery occlusion. At the same time, patients with blood-brain barrier disruption are at a higher risk of poor early prognosis, so more active treatment should be given clinically to maximize the improvement of clinical outcome.
引用
收藏
页码:279 / 283
页数:5
相关论文
共 50 条
  • [1] RISK FACTORS OF BLOOD-BRAIN BARRIER INJURY IN PATIENTS WITH ACUTE ISCHEMIC STROKE AND ITS RELATIONSHIP WITH PROGNOSIS OF ENDOVASCULAR THERAPY
    Zhang, Jiajia
    Zhou, Hang
    Deng, Chensong
    Gu, Wenju
    ACTA MEDICA MEDITERRANEA, 2022, 38 (06): : 4183 - 4186
  • [2] Early Blood-Brain Barrier Disruption after Mechanical Thrombectomy in Acute Ischemic Stroke
    Shi, Zhong-Song
    Duckwiler, Gary R.
    Jahan, Reza
    Tateshima, Satoshi
    Szeder, Viktor
    Saver, Jeffrey L.
    Kim, Doojin
    Sharma, Latisha K.
    Vespa, Paul M.
    Salamon, Noriko
    Villablanca, J. Pablo
    Vinuela, Fernando
    Feng, Lei
    Loh, Yince
    Liebeskind, David S.
    JOURNAL OF NEUROIMAGING, 2018, 28 (03) : 283 - 288
  • [3] Good outcome associated with blood-brain barrier disruption and lower blood pressure after endovascular therapy
    Upadhyaya, Parth
    Mehta, Amit
    Luby, Marie
    Ansari, Saeed
    Lynch, John K.
    Hsia, Amie W.
    Latour, Lawrence L.
    Kim, Yongwoo
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2023, 32 (01)
  • [4] Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis
    Fortin, David
    Gendron, Cathy
    Boudrias, Marie
    Garant, Marie-Pierre
    CANCER, 2007, 109 (04) : 751 - 760
  • [5] L-NAME reduces infarction, neurological deficit and blood-brain barrier disruption following cerebral ischemia in mice
    Ding-Zhou, L
    Marchand-Verrecchia, C
    Croci, N
    Plotkine, M
    Margaill, I
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 457 (2-3) : 137 - 146
  • [6] Effects of rapamycin pretreatment on blood-brain barrier disruption in cerebral ischemia-reperfusion
    Chi, Oak Z.
    Mellender, Scott J.
    Barsoum, Sylviana
    Liu, Xia
    Damito, Stacey
    Weiss, Harvey R.
    NEUROSCIENCE LETTERS, 2016, 620 : 132 - 136
  • [7] Edaravone dextranol alleviates ferroptosis, Cuproptosis, and blood-brain barrier damage after acute cerebral infarction
    Jin, Guimin
    Han, Wei
    Duan, Tingting
    Xue, Zongwei
    Song, Chenglin
    Xu, Yuhao
    Yu, Ming
    METABOLIC BRAIN DISEASE, 2025, 40 (03)
  • [8] Blood-brain barrier disruption and hemorrhagic transformation in acute stroke before endovascular reperfusion therapy
    Liang, Yuchen
    Yu, Yang
    Liu, Jiaxin
    Li, Xuewei
    Chen, Xue
    Zhou, Hongwei
    Guo, Zhen-Ni
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [9] The Blood-Brain Barrier: Its Influence in the Treatment of Brain Tumors Metastases
    Fortin, D.
    CURRENT CANCER DRUG TARGETS, 2012, 12 (03) : 247 - 259
  • [10] In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans
    Siegal, T
    Rubinstein, R
    Bokstein, F
    Schwartz, A
    Lossos, A
    Shalom, E
    Chisin, R
    Gomori, JM
    JOURNAL OF NEUROSURGERY, 2000, 92 (04) : 599 - 605